IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee.
Frequently asked questions
What sector does IMAC Holdings Inc (BACK) operate in?
IMAC Holdings Inc belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is IMAC Holdings Inc (BACK) current stock price?
As of the latest data, IMAC Holdings Inc stock price is $0.00, with a previous close of $0.00. IMAC Holdings Inc gained $0.00 in the last trading session, representing a 33.33% increase.
What is IMAC Holdings Inc (BACK) current market capitalization?
IMAC Holdings Inc market cap is approximately 1.51 thousand.
What is IMAC Holdings Inc (BACK) Earnings Per Share (EPS)?
The trailing EPS is -$2.98.
Does IMAC Holdings Inc (BACK) pay dividends?
No. IMAC Holdings Inc does not pay a dividend.
What is IMAC Holdings Inc (BACK) beta (volatility) score?
IMAC Holdings Inc has a beta of 1.783, suggesting it is more volatile than the market.